ARL6IP5 and Parkinson disease: The detailed mechanistic studies to understand its beneficial effect revealed that overexpression of ARL6IP5 significantly reduced toxic aggregates, reduced toxicity in LDH assay, and induced differentiation in the cellular model of PD (Figure 2A–D).